Stagnaro-Green [31] emphasized that identifying women at risk of developing postpartum thyroiditis (PPT) may result in focused postpartum screening and that A-TPO measured in the first trimester is the ideal screening tool. The gene discussed is TPO; the disease is postpartum thyroiditis.